GLP-1 Therapies: Where We’ve Been & Where We’re Going
When we first featured a guest discussing GLP-1 therapies, the public’s understanding of these drugs to treat obesity was still developing. In 2023, our expert was Dr. Jamy Ard, the then-incoming president of The Obesity Society. Even then, Dr. Ard was stressing that more choices would lower prices for consumers. We look back on that […] The post GLP-1 Therapies: Where We’ve Been & Where We’re Going appeared first on Healthy Communities Online.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from Conversations on Health Care
Which U.S. Senator in His Early 20s Helped Save a Community Health Center?
Can AI Find Medicaid Fraud? That’s the Mission of Stephanie Carlton, Dep. Admin, CMS
Insights & Inspiration: Building the Community Health Center’s Next Chapter
America’s Health Story: 250 Years of Innovation
Get summaries like this every morning.
Free AI-powered recaps of Conversations on Health Care and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.